NORDIC LABORATORIES ApS: Financial statements 2023
CVR: 26672953
Source: annual report 2023, Danish Business Authority
01/07/2022 – 30/06/2023
NORDIC LABORATORIES ApS (CVR 26672953) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 6,814,092 and a net result of DKK 594,495 compared with DKK -762,459 the year before. That is a decrease of 7% compared with the year before. Equity in the 2023 report amounted to DKK 1,834,133. The solvency ratio was 26.5%. The company had 12 employees in the financial year.
- Gross Profit
- DKK 6,814,092
- Profit/Loss
- DKK 594,495
- Equity
- DKK 1,834,133
- Total Assets
- DKK 6,918,208
- Employees
- 12
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 6.8 mio. | 594 t. | 1.8 mio. | 12 |
| 2022 | - | 7.3 mio. | -762 t. | 1.2 mio. | 12 |
| 2021 | - | 9 mio. | 2.2 mio. | 4.9 mio. | 11 |
| 2020 | - | 7.6 mio. | 1.7 mio. | 4.2 mio. | 10 |
| 2019 | - | 6.7 mio. | 1.6 mio. | 3 mio. | 8 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationAbout NORDIC LABORATORIES ApS
NORDIC LABORATORIES ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2002. The company is registered under the industry Aktiviteter inden for hospitalsvæsen. The company was previously named ApS KBIL 38 NR. 2431. The management consists of Christopher John Liebe Moore. The company is owned by NORDIC GROUP ApS. The company has 22 employees (2026). In 2025, the company reported a gross profit of DKK 11,578,808 and a net result of DKK 2,826,553 compared with DKK 4,319,759 the year before. Equity in the 2025 report amounted to DKK 4,080,445.